W2 LECT 2: Megaloblastic Anaemia Flashcards

1
Q

What is macrocytosis?

A

Is an increase in the size of the erythrocytes, where the red
cells are abnormally large.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Reflects the red cell size on the Full blood count (FBC)

A

Mean Cell Volume diagnosed on the peripheral blood smear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the normal shape of macrocytes IN MEGALOCYTOSIS?

A

Oval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the cause of macrocytic anemias?

A

They result from abnormal
erythropoiesis, and are broadly subdivided into megaloblastic and non-megaloblastic macrocytic anemias.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the causes of megaloblastic anaemia?

A
  1. Vitamin B12/Cobalamin deficiency
  2. Folic acid deficiency
  3. Abnormalities of B12 or folate
    metabolism (eg: antifolate drugs,
    nitrous oxide, TC deficiency).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Features of megaloblastic anemias

A
  • A group of disorders characterized by characteristic abnormality in the developing
    red cells within the bone marrow:
  • asynchronous maturation :
    *Maturation of the nucleus is delayedcompared to the cytoplasm
  • The underlying problem is defective DNA synthesis which affects all rapidly dividing
    cells.
  • Most commonly caused by a deficiency of vitamin B12 or folate.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the biochemical basis of megaloblastosis

A
  • Megaloblastic anemia’s underlying cause if defective DNA synthesis
  • B12 and folate deficiencies lead to failure of deoxyuridine monophosphate (dUMP)
    conversion into deoxythymidine monophosphate(dTMP)
  • This results in a decreased supply of deoxythymidine triphosphate (dTTP) for DNA
    synthesis, where (dUMP) is continuosly added on a growing DNA chain followed by fragmantation of the chain as DNA polymerase breaks it in attempt to correct the errors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the sources of folate?

A

liver, yeast, nuts, spinach
and other leafy greens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is folate daily requirement?

A

~100μg.
* Folate is easily destroyed by cooking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How long can folate last on the body stores upon it uptake?

A

4 months; therefore
folate deficiency can develop rapidly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Discuss the absorption of folate from food in the stomach to the plasma

A
  • Most folate is absorbed in the upper small
    intestine.
  • Folate transporter proteins are located on the
    mucosal surfaces of the duodenum and to a
    lesser extent the jejunum.
  • Dietary folate is converted to 5 methyl THF within the small intestinal mucosa before
    entering the plasma.
  • Folate is transported in the plasma ~1/3 being
    bound to albumin and the remainder unbound. It
    is then actively transported into the cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the causes of folate deficiency?

A
  • Dietary: old age, alcoholism, institutuions, poverty, infants fed on goats milk.
  • Malabsorption: Tropical sprue, gluten-induced enteropathy,
    jejunal resection, partial gastrectomy, Crohn’s disease.
  • Excess utilization or loss:
  • Physiological: Pregnancy, lactation, prematurity.
  • Pathological: Haematological diseases (SCA, haemolytic
    anaemia), malignant diseases (lymphoma, myeloma)
    inflammatory (TB, Crohn’s)
  • Excess urinary loss: CCF, liver disease.
  • Long term dialysis
  • Antifolate drugs: anticonvulsants, drugs which inhibit dihydrofolate reductase (methotrexate).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The main enzyme involved in the folate metabolism pathway. Its inhibition can disrupt folate metabolism in rapidly dividing cells of the bone marrow, leading pancytopenia

A

Dihydrofolate reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drugs that intefere with utilisation or absorbtion of folate into the plasma by inhibiting dihydrofolate reductase

A
  • antileukaemic drugs (e.g. methotrexate),
  • antimalarials (e.g.
    pyrimethamine) and
  • antibiotics (e.g. trimethoprim) may interfere with utilisation of
    folate.

NB Alcohol appears to have a direct effect preventing the use of folate by the marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the human source of Vitamin B12?

A

foods of animal origin:
liver, meat, fish, chicken and
(eggs cheese and milk)
*Unlike folate, it is not destroyed by cooking

In animals the vitamin is made by microorganisms

17
Q

What are the daily requirements of B12?

A

Daily requirements are
about 1-5μg.

18
Q

How long can B12 last on the body stores upon it uptake?

A

Body stores are sufficient
for 3-4 years.

19
Q

Discuss the trasportation of B12/cobalamin from the stomach into the plasma

A
  • B12 in the stomach is released from food by digestive proteases as well as gastric acid.
  • It is made to bind protein R-binders in the stomach
  • Complex is transported to the dodenum where B12 is separated from R binders (by digestive proteolysis) and made to bind to Intrinsic factor (secreted by the parietal cells)
  • The B12-Intrinsic factor complex moves to the ileum and bind to the receptor on the ileal enterocytes
  • Once absorbed, IF is degraded and the cobalamin is transferred to the plasma where it is bound to transcobalamin and haptocorrin.
  • The biologically active fraction is that bound to transcobalamin BUT there may be MORE bound to haptocorrin
  • The Vitamin B12-Transcobalamin (TCII) complex binds to a membrane receptor present on the surface of many
    cell types including bone marrow.
  • The complex enters the cells, the TCII is digested and
    the Vitamin B12 released.
20
Q

Why is most B12 bound to haptocorrin?

A

for storage in the liver

21
Q

CLINICAL FINDINGS COMMON TO ALL MEGALOBLASTIC ANAEMIAS

A
  • Many patients are asymptomatic as the anaemia develops slowly. These patients may be detected on a routine FBC where they are found to have a macrocytosis.
  • In severe megaloblastic anaemia the symptoms are
    those of:
    1. Anaemia: weakness, fatigue, palpitations, light-headedness and shortness of breath.
    2. Thrombocytopenia: may cause bruising.
    3. Neutropenia: may predispose to infections.
    4. Mild jaundice due to increased unconjugated
    hyperbilirubinaemia (ineffective erythropoiesis)
    5. Others: glossitis (beefy red sore tongue), angular
    cheilosis, LOW.
21
Q

What are the causes of severe B12 deficiency?

A
  • Nutritional:
    -Vegans, breastfed infants of vitamin B12 deficient
    mothers
  • Impaired absorption
    –Gastric causes:
    -Pernicious anaemia. Gastric atrophy
    -Total or partial gastrectomy. Gastric bypass
    -Congenital deficiency of IF.
    -Medications: PPI, metformin, nitrous oxide abuse

– Intestinal causes:
-Ileal resection or dysfunction (Crone’s disease, celiac)
-Intestinal lymphoma, bacterial overgrowth from blind loop
syndrome
-Fish tapeworm (competition for host vitamin B12).
- Congenital disorders of Vit B12 transport: TC deficiency.

22
Q

Name the dividing, DNA synthesizing cells, affected by Vitamin B12 and/or folate deficiency

A
  • The bone marrow is most affected followed by
  • epithelial surfaces of the GIT,
  • respiratory,
  • urinary
    and female genital tract.

*The cells are large and fragile and there is an increase in the numbers of dying cells.

23
Q

Associated with the development of neural tube defect on foetus;
and may also cause mental changes such as depression

A

Folate deficiency

*Supplementation with folic acid from conception
for the first 12 weeks of pregnancy has decreased the incidence of NTD’s
tube defects by 70-75%.

24
Q

NEUROLOGICAL ABNORMALITIES
DUE TO VITAMIN B12 DEFICIENCY

A
  • Bilateral peripheral neuropathy. symmetrical. LL >UL (more on lower limbs than upper limbs)
  • Subacute combined degeneration of the spinal cord
  • Demyelination of the posterior and lateral columns of the
    spinal cord.

Presentation:
* Paresthesia’s (tingling) in the feet, disturbances of vibratory sense and proprioception with difficulty walking. May fall over in the dark
* Occasionally visual impairment, dementia and psychotic disturbances
(megaloblastic madness)

25
Q

Discuss the laboratory investigations in the diagnosis of megaloblastic anaemia

A

HAEMATOLOGICAL FINDINGS:
Vitamin B12 and folate deficiency have the exact same haematological features.
1. FBC:
* RBC - Decreased
* Hb - Decreased
* HCT - Decreased
* MCV - Increased
* MCHC - Normal Ineffective haemopoiesis
* RDW - Increased (anisocytosis)
* WBC - Decreased
* PLT - Decreased

*Ineffective erythropoiesis

  1. PANCYTOPENIA: anaemia, neutropenia and thrombocytopenia
  2. RPI – Low for the degree of anaemia.
26
Q

Biochemical evidence of ineffective erythropoiesis includes:

A
  1. Unconjugated hyperbilirubinaemia.
  2. Decreased haptoglobin levels.
  3. Raised urine urobilinogen.
  4. Raised LDH.

These findings are the same as those noted in certain haemolytic anaemias

27
Q

FEATURES OF NORMAL MCV IN
MEGALOBLASTOSIS;WITH CO-EXISTING IRON DEFICIENCY

A
  • May see a dimorphic red cell picture with both
    macrocytes and microcytic hypochromic red cells.
    – MCV may be normal
  • Coexisting thalassaemia trait may also result in a normal
    MCV in the presence of megaloblastosis.
  • Red cell fragments
28
Q

HOW TO DIAGNOSE FOLATE
DEFICIENCY?

A
  • Serum folate:
    -Is low in all folate deficient patients.
    -It is markedly affected by diet.
    -Inadequate intake for as little as one week may result in low levels.
  • Red cell folate:
    –Reflects body stores and is less affected by diet.
    –Low levels seen in folate deficiency, but, also in vitamin B12 deficiency, subsequently vitamin B12 deficiency must be
    excluded when interpreting a low red cell folate level.

*Serum folate is the only available test within the NHLS: need to write it on the form!

29
Q

HOW TO DIAGNOSE VITAMIN B12
DEFICIENCY?

A
  • Serum vitamin B12:
    levels are low in most
    patients with megaloblastic anaemia due to vitamin B12 deficiency.
  • Serum methylmalonic acid (MMA) and
    homocysteine levels are increased. Not
    offered in NHLS
30
Q

How to treat B12 deficiency?

A
  • Body stores should be replaced after six
    1000μg intramuscular injections given
    every 3-7 days.
  • Maintenance therapy involves 1000μg IMI
    given every three months
30
Q

TREATMENT FOR MEGALOBLASTIC ANAEMIA

A
  • In most cases replacement therapy with the appropriate vitamin is given based on the laboratory test results.
  • In patients with severe symptoms:
    – Blood for both folate and Vitamin B12 levels should be taken.
    – Bone marrow aspirate and trephine biopsy may be necessary.
    – Replacement therapy with both B12 and folate should then be started. If large doses of folate are given in the presence of Vitamin B12 deficiency they may aggravate the neuropathy.
    – Patients must be monitored for hypokalaemia (increased potassium levels).
  • Avoid blood transfusion if possible.
    – If absolutely essential packed cells should be given very slowly.
    Patients must be closely monitored for pulmonary oedema and
    circulatory overload.
    – Platelets may be necessary for patients with spontaneous
    bleeding due to a severe thrombocytopenia.
31
Q

How to treat folate deficiency?

A
  • Given orally.
  • Dose 5-15mg daily. Adequate folate is absorbed at
    these high doses even in patients with malabsorption.
  • Therapy should continue for 4 months.
  • Prior to giving large doses of folate it is important to
    exclude Vitamin B12 deficiency.
  • Long term therapy is indicated in patients in whom the
    cause for the deficiency cannot be corrected such as
    chronic haemolysis due to thalassaemia or sickle cell
    anaemia.
  • Patients receiving long term folate therapy should
    have their Vitamin B12 levels checked annually.
32
Q

MEGALOBLASTOSIS PROPHYLACTIC THERAPY

A
  • Folic acid is given during pregnancy (5mg daily)
    and it is recommended that woman of child
    bearing age have an increased intake of folate in
    an attempt to avoid NTD’s.
  • Mandatory food fortification with folate was implemented in South Africa in October 2003.
  • Folic acid is given to patients on chronic dialysis, with severe chronic haemolytic anaemias and to premature infants.
  • Vitamin B12 is given for life to patients who have
    had a total gastrectomy or ileal resection.